RE: Now on Proactive - very unconvincing6 Dec 2025 09:45
Bubsy, I have only ever been here for Croda and the fact they gave us over £700k gives me great encouragement, I think the biggest thing that has spooked investors is the forecast, it doesnt look good, but I dont believe it for one minute, its been lowballed. What he needs to do next week is upgrade guidance immediately and then hand in his resignation. I posted this on Substack yesterday, it just shows he is either a liar or incompetent, or both. I shall let others decide.
FY25
Derma £2.2m
BTS £1.4m
Axis £0.28m
Croda £0.7m (Table 15 Trade and other receivables) Accrued Income £769k
Total £4.58m
Lets assume Derma & BTS only hit FY25 forecasts and we get zero growth in Axis (inc Superdrug) or Croda. Figures below:
Derma £2.9m
BTS £3.0m
Axis £0.28m (inc SD)
Croda £0.7m
Total £6.88m
Plus, lets not forget the missed orders which dropped in to H1 26, lets call it £500k, which takes us to £7.38m. Remember, thats with Zero growth!
“Market expectations for the year ending 30 June 2026; revenue of £6.2 million and adjusted EBITDA of £0.7”
So would anybody like to explain, how we are only going to do £6.2m, if as per the Proactive interview everything is going really well?
All the best